References
- Goudard M, Buffard Y, Ferrari H, et al. Spectre d'action in vitro d'un nouvel antifongique dérivé de la naftifine: la terbinafine (SF 86–327). Pathol Biol 1986; 34: 680–3
- Petranyi G, Meingassner J G, Mieth H. Antifungal activity of the allylamine derivative terbinafine in vitro. Antimicrob Agents Chemother 1987; 31: 1365–8
- Shadomy S, Espinel-Ingroff A, Gebhart R J. In-vitro studies with SF 86–327, a new orally active allylamine derivative. J Med Vet Mycol 1985; 23: 125–32
- Clayton Y M. In vitro activity of terbinafine. Clin Exp Dermatol 1989; 14: 101–3
- Shaw J C, Levinson W, Montanaro A. Sporotrichosis in the acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 21: 1145–7
- De Beurmann L, Ramond L. Abcès souscutanés multiples d'origine mycosique. Ann Dermatol Syphiligr 1903; 4: 678
- Rex J H, Bennett J E. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol 1990; 28: 185–9
- Pluss J L, Opal S M. Pulmonary sporotrichosis: Review of treatment and outcome. Medicine 1986; 65: 143–53
- Restrepo A, Robledo J, Gomez I, et al. Itraconazole therapy in lymphatic and cutaneous sporotrichosis. Arch Dermatol 1986; 122: 413–7
- Baker J H, Goodpasture H C, Kuhns H R, et al. Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole. Arch Pathol Lab Med 1989; 11: 1279–81
- Montero-Gei F, Syevens D A, Siles L, et al. Fluconazole therapy in cutaneous and lymphangitic sporotrichosis. Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia, 1990, 182, Abstract
- Kan V L, Bennett J E. Efficacies of four antifungal agents in experimental murine sporotrichosis. Antimicrob Agents Chernother 1988; 32: 1619–23